Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Enkhtseteg Purev
Chimeric Antigen Receptor T Cells for the Treatment of Lymphoma
Annals of Lymphoma
Related publications
Chimeric Antigen Receptor T-Cells
Cancer Journal
Cancer Research
Oncology
Cd30-Chimeric Antigen Receptor (Car) T Cells for Therapy of Hodgkin Lymphoma (Hl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Chimeric Antigen Receptor T-Cells (Car-T) for Refractory and Relapsed Burkitt's Lymphoma: Early Response in Pediatric Patients
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
204. HER2-Specific Chimeric Antigen Receptor T Cells for the Treatment of Breast-To-Brain Metastasis
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
768. Improved Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Refractory and Relapsed Leukemia
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Chimeric Antigen Receptor Transduced T Cells - Tuning Up for the Next Generation
International Journal of Cancer
Cancer Research
Oncology
The Promise of Chimeric Antigen Receptor T Cells (CARTs) in Leukaemia
British Journal of Haematology
Hematology
Pre-Clinical Evaluation of CD38 Chimeric Antigen Receptor Engineered T Cells for the Treatment of Multiple Myeloma
Haematologica
Hematology